Deadpool blend
BPC-157 + TB-500 + Cartalax
A supplier blend of BPC-157, TB-500 and Cartalax sold under a brand name rather than a formulation standard.
Regulatory status: Not a medicine. None of the three components is approved, and one of them — Cartalax — has almost no published research of any kind.
Default vial
30 mg
Default mix
3 mL
Reported range
Varies with the blend ratio
Draw (U-100)
5 u
A supplier blend of BPC-157, TB-500 and Cartalax. All three have their own entries and none has human dosing data; Cartalax has almost no research of any kind. The name is marketing, not a formulation standard — contents vary.
Where these numbers come from
No human dosing trial defines a dose for this compound. The numbers here are the values community calculators pre-fill — reference only. None of the three components has a human dosing trial, and Cartalax has almost no published research of any kind. "Deadpool" is a supplier name, not a formulation standard.
Reviewed October 2026
What it is
- Three compounds in one vial: BPC-157, TB-500 and Cartalax. Each has its own Pep-Tidy entry.
- “Deadpool” is a supplier name. It does not define what is in the vial, and different suppliers use it differently.
- Cartalax is the weakest-evidenced of the three: the one published study naming it is a cell-culture paper, and most literature attributed to it is actually about Epitalon, a different peptide.
- Investigational components only.
How it is described to act
- 1
Given as one subcutaneous injection containing all three.
- 2
Each component behaves as it does alone.
- 3
The rationale offered is combined tissue repair; nothing published tests it.
- 4
No outcome has been measured for the combination.
What the research has looked at
What the research covers
- BPC-157 and TB-500 have animal and cell literature, covered in their own entries. Neither has a human dosing trial.
- Cartalax has one published cell-culture paper naming it. Buying a three-component blend means buying that one too.
- No published study tests this combination.
Strength of evidence: Preclinical evidence only
No study tests this combination, and one component has essentially no research of its own.
What is published comes from cell and animal studies. Findings in those models frequently do not carry over to people.
Reported cautions and unknowns
- A blend is several compounds at once, so an adverse effect cannot be traced to any one of them. Running components separately first is the only way to know which does what.
- Ratios are set by the supplier, not by any standard, so two vials with the same name can contain quite different amounts.
- The safety of the combination has not been studied. What is known, where anything is known, applies to each compound on its own.
- There are no combined pharmacokinetic or toxicity data for any of these blends, so interaction risk is unquantified.
- The FDA's 2026 compounding-committee briefing on BPC-157 documented adverse-event reports and gaps in impurity characterisation for that single peptide.
- Sterility, identity and concentration of multi-peptide compounded vials vary by supplier; only a current third-party Certificate of Analysis can confirm what a vial actually contains.
References
There are none. A search of the published literature returns no studies of this compound — no human trials, no animal work, no cell studies. Anything claimed about it elsewhere is not drawn from published research on this molecule.
Handling this vial
- Lyophilized vials are generally stored at 2–8 °C and kept out of light; once reconstituted with bacteriostatic water they are refrigerated and commonly discarded after 28 days.
- Mix by aiming water down the vial wall and rolling gently — do not shake — and never re-freeze a reconstituted vial.
- Pep-Tidy cannot verify what is in your vial. Ask your supplier for a current Certificate of Analysis (HPLC/MS).
Deadpool blend questions people ask
How do you reconstitute Deadpool blend?
A common starting point for a 30 mg vial of Deadpool blend is 3 mL of bacteriostatic water, which gives 10 mg per mL. Aim the water down the inside wall of the vial, let it dissolve on its own, and roll gently instead of shaking. Pep-Tidy's reconstitution calculator will recalculate the numbers for any other vial size or water volume you use.
How many units of Deadpool blend is one dose?
At 10 mg per mL, that works out to about 5 units on a U-100 insulin syringe for a 500 mcg dose. Change the vial size, water volume, or target dose in the calculator and the syringe reading updates with it. This is arithmetic, not a dosing recommendation.
What dosing schedule is reported for Deadpool blend?
Published and community sources describe Varies with the blend ratio, subcutaneous, every day, typically run 4 weeks on and 2 weeks off. These figures describe what has been reported, not what anyone should take — talk to a licensed clinician first.
How should Deadpool blend be stored?
Lyophilized Deadpool blend vials are generally kept at 2–8 °C and out of light. Once reconstituted with bacteriostatic water they are refrigerated and commonly discarded after about 28 days. Never re-freeze a reconstituted vial and never shake it.
Read this before you act on anything above
Everything on this page is a summary of what other people have published — it is not medical advice, not a recommendation, and not a dosing instruction. Reported dose ranges describe what appears in the literature or in community protocols, not what anyone should take. Talk to a licensed clinician before using any peptide.